Business Wire

ZYXEL

27.2.2024 16:55:34 CET | Business Wire | Press release

Share
Türk Telekom Achieves the World’s First Mass Deployment of Software-defined Fiber Broadband With Zyxel and Netsia

Türk Telekom, pioneer of digital transformation Türkiye, has completed the world’s first mass deployment of Software-Defined Fiber Broadband. By using Netsia’s BB Suite and Zyxel’s Whitebox OLT, Türk Telekom has taken an important step towards fulfilling its virtualized and disaggregated broadband network strategy and thus, providing world-class, modern, high quality and high-speed broadband services.

“Beyond our role as a telecommunications operator, we are leading Türkiye's ambition to become a significant player in technology exports through our pioneering initiatives and partnerships. While supporting our local ecosystem through collaborations within our country, we are also elevating the prestige and value of our nation through our global endeavors," says Ümit Önal, CEO at Türk Telekom. “The cutting-edge fiber infrastructure technology product Zyxel, developed by Argela, our company renowned for innovative solutions, along with its US subsidiary Netsia, has evolved into an innovation that sets global standards. We are delighted to contribute to our country's vision of becoming a technology-exporting nation through the contract we have signed with Zyxel.”

Zyxel and Netsia have successfully completed the integration of Zyxel’s SDA Series Combo Whitebox OLT with Netsia’s BB Suite to realize the fully disaggregated broadband access network. The integrated solution has been tested in Türk Telekom’s live network and is now ready for deployment by all service providers globally. The partnership was made official with a contract signing ceremony held at this year’s Mobile World Congress on February 27. In attendance for the signing ceremony was Republic of Türkiye Deputy Transport and Infrastructure Minister Ömer Fatih Sayan.

The Netsia BB Suite provides network operators with an open, multi-vendor platform based on open-source SEBA project and BBF data models. Netsia BB Suite enables network operators to extend software defined programming to the fixed access network with customized support for each operator’s unique services and workflows. By enabling a fully disaggregated network, service providers are no longer committed to one vendor to fulfill all their needs. Instead, they have full flexibility to choose products and partners that work best for them, while having the flexibility to customize the solution to their needs.

Türk Telekom chose Zyxel’s Multi SDA products , which are all-in-one PON Whitebox OLT’s that are fully equipped to provide scalability, flexibility and interoperability to the Netsia BB Suite. The OLT’s have features that simultaneously support XGS-PON, GPON and Combo PON technologies, designed to make it easier for operators to adopt new technologies that integrate seamlessly with this solution.

“Netsia’s BB Suite is one of the most mature versatile solutions in the market, and our SDA Series Combo is designed to jointly further the network disaggregation evolution,” says Karsten Gewecke, President at Zyxel Communications. “We wanted to develop a flexible, future proof solution that creates an open broadband-access environment with vendor-agnostic hardware, keeping service providers ahead of the competition.”

Netsia CEO C. Bora Eliaçık says: “Türk Telekom, a globally recognized leader in telecommunications, is at the forefront of innovation in the Software-defined Fiber Broadband arena. We are honored to partner with them on this transformative journey. Our Netsia BB Suite product is designed to revolutionize how operators manage their access networks by providing a unified, powerful management solution. This collaboration marks a significant milestone in the evolution of access network management.” Eliaçık adds: “Our BB Suite allows the broadband access network to adapt itself to different service requirements and customer experience needs. The solution also supports the operators to optimize the CAPEX and OPEX costs by breaking the vendor lock, allowing more controllable and flexible PON networks and thus enabling critical features and services in the network. Our cooperation with Zyxel is extremely fruitful and we thank them for their collaboration and look forward to continuing our successful partnership.”

About Türk Telekom:

Türk Telekom, with over 180 years of history, is the first integrated telecommunications operator in Türkiye. Having a wide service network and product range in the fields of individual and corporate services, Türk Telekom unified its mobile, internet, phone and TV products and services under the single “Türk Telekom” brand. “Türkiye’s Multiplay Provider” Türk Telekom has 17.4 million fixed access lines, 15.1 million fixed broadband, 26.1 million mobile and 2.9 million TV subscribers as of September 30, 2023. Türk Telekom Group Companies provide services in all 81 cities of Türkiye with nearly 38.000 employees with the vision of introducing new technologies to Türkiye and accelerating Türkiye’s transformation into an information society. www.turktelekom.com.tr

About Netsia:

Netsia, a US subsidiary of Argela, is based in Santa Clara, California in the heart of Silicon Valley. With key architects, engineers and product people, Netsia is developing leading edge solutions for the telecom industry. Netsia is in active participation with open source communities and standards bodies and provides enriched, telco-grade, and supported distributions of the open source platforms. www.netsia.com

About Zyxel Communications

Zyxel Communications delivers technological innovations and has connected the world to the internet for more than 30 years. Whether establishing access through fixed or mobile broadband solutions, Zyxel Communications offers a comprehensive and flexible portfolio of products that’s keeping service providers ahead of the competition. Come by our booth at MWC 2024 to know more about our solutions and partnerships: Homepage | EMEA | Zyxel

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240227158748/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Yubico Appoints Poupak Modirassari Enbom as Chief Marketing Officer to Accelerate Global Momentum and Drive Market Leadership30.3.2026 15:00:00 CEST | Press release

Yubico (NASDAQ STOCKHOLM: YUBICO), the creator of the most secure passkeys and a leading provider of hardware authentication security keys, today announced the appointment of Poupak Enbom as Chief Marketing Officer (CMO). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330278027/en/ Enbom joins Yubico at a pivotal moment as organizations worldwide accelerate the shift to phishing-resistant authentication and modern identity security in the age of AI. “We’re excited to welcome Poupak to Yubico,” said Jerrod Chong, acting chief executive officer, Yubico. “As the threat landscape evolves with AI-driven attacks and increasing automation, organizations are rethinking how they secure digital identities of both humans and AI agents at scale. She brings a unique combination of technical depth, global leadership, and customer-first mindset that will help us continue to expand our impact and support our customers and partners around

Westinghouse Celebrates Record-breaking 80 Years of Nuclear Fuel Manufacture at Springfields30.3.2026 14:00:00 CEST | Press release

Fuel manufactured at Springfields has generated enough energy to supply the UK’s electricity demand for 26 years, avoiding the emission of nearly 3 billion tonnes of CO2 The Westinghouse Springfields facility in Lancashire, UK, has marked a significant milestone as the oldest continuous nuclear fuel manufacturing site in the world, starting from its original license on the 28th, March 1946. The site was chosen by the UK Government to develop nuclear fuel for the world’s earliest civil nuclear power stations, as well as subsequent Magnox and Advanced Gas Reactors (AGR) reactors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330135973/en/ From left to right: Sophie Lemaire; Marc Chevrel; Rory O'Neill; Craig Boothby; and Robert Gofton, CEO at Nuclear Institute Across the last eight decades, the Springfields site has supported the UK nuclear fleet, manufacturing more than eight million AGR pins, sintering and pressing over 5

HistoSonics Treats First Patients Evaluating the Edison® Histotripsy System for the Treatment of Benign Prostatic Hyperplasia (BPH)30.3.2026 14:00:00 CEST | Press release

HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, today announced the successful treatments of the first patients in WOLVERINE, a prospective feasibility trial evaluating the Edison® Histotripsy System for the treatment of benign prostatic hyperplasia (BPH) at Prince of Wales Hospital in Hong Kong, a teaching hospital for The Chinese University of Hong Kong. The Edison System is a novel, non-invasive, image guided platform that uses the mechanical properties of focused ultrasound, called histotripsy, to destroy unwanted tissue without the need for invasive procedures, and with potentially fewer side effects than traditional, invasive therapies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330349844/en/ HistoSonics Non-Invasive Edison Histotripsy System. Image credit: HistoSonics WOLVERINE is a prospective, multi-center, single-arm feasibility trial designed to evaluate

Biocytogen Grants Taisho Pharmaceutical a License to its RenNano® Fully Human Heavy Chain-Only Antibody Discovery Platform30.3.2026 13:00:00 CEST | Press release

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a platform license agreement with Taisho Pharmaceutical Co., Ltd. (“Taisho”), granting Taisho the right to access and use Biocytogen’s proprietary RenNano® fully human heavy chain-only antibody (HCAbs) discovery platform for its internal research and development programs. Under the terms of the agreement, Taisho will leverage RenNano® mice to enable the generation and screening of fully human HCAbs in vivo and to support downstream research associated with antibody discovery. Financial terms of the agreement have not been disclosed. “We are very pleased to enter into this collaboration with Taisho,” said Dr. Yuelei Shen, President and CEO of Biocytogen. “RenNano® is a robust and powerful fully human VHH discovery platform that pro

Meiji Seika Pharma Invests in Centivax to Develop Next Generation Universal Vaccine Platform30.3.2026 13:00:00 CEST | Press release

Meiji Seika Pharma Co., Ltd. (Head Office: Chuo-ku, Tokyo, President and Representative Director: Toshiaki Nagasato) today announced a strategic investment in Centivax, Inc. (Head Office: South San Francisco, CA, USA), a biotechnology company developing next-generation vaccines and therapies for universal protection against highly diverse targets. Centivax’s lead program includes a universal seasonal influenza vaccine (Centi-Flu 01) currently in a Phase 1 clinical study. Unlike conventional seasonal flu vaccines, which must be manufactured annually based on recommended candidate vaccine viruses, Centivax’s platform focuses both antibody and cellular immune responses on conserved regions of the influenza virus that cannot mutate and are shared across strains and distant subtypes. This approach aims to generate broad, consistent, and durable immunity against both seasonal and pandemic influenza. Meiji’s strategic investment aims to accelerate the advancement of Centi-Flu 01 and further a

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye